These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 5001703)

  • 1. Cells mediating specific in vitro cytotoxicity. I. Detection of receptor-bearing lymphocytes.
    Golstein P; Erik MD; Svedmyr AJ; Wigzell H
    J Exp Med; 1971 Dec; 134(6):1385-402. PubMed ID: 5001703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific inactivation of cytotoxic lymphocytes after adsorption on 51Cr-labeled fibroblast monolayers.
    Ritter J; Lohmann-Matthes ML; Fischer H
    Transplantation; 1973 Dec; 16(6):579-82. PubMed ID: 4148250
    [No Abstract]   [Full Text] [Related]  

  • 3. Specific adsorption of cytotoxic thymus-processed lymphocytes (T cells) on glutaraldehyde-fixed fibroblast monolayers.
    Golstein P; Svedmyr EA; Blomgren H
    Eur J Immunol; 1972 Aug; 2(4):380-3. PubMed ID: 4628413
    [No Abstract]   [Full Text] [Related]  

  • 4. Mediation of immune responses to tumor antigens in vitro by immune RNA.
    Kern DH; Drogemuller CR; Pilch YH
    Ann N Y Acad Sci; 1976; 276():278-302. PubMed ID: 1071964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro induction of tumor-specific immunity. I. Parameters of activation and cytotoxic reactivity of mouse lymphoid cells immunized in vitro against syngeneic and allogeneic plasma cell tumors.
    Wagner H; Röllinghoff M
    J Exp Med; 1973 Jul; 138(1):1-15. PubMed ID: 4541509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fractionation of antigen reactive cells on a cellular immunoadsorbent: factors determining recognition of antigens by T-lymphocytes.
    Wekerle H; Lonai P; Feldman M
    Proc Natl Acad Sci U S A; 1972 Jun; 69(6):1620-4. PubMed ID: 4504379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. H-2 private specificity of in vivo-sensitized lymphocytes studied by adsorption on fibroblast monolayers.
    Jorgensen PN; Güttler F; Rubin B
    Scand J Immunol; 1975; 4(4):383-9. PubMed ID: 52890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of the in vitro development of cytotoxicity against alloantigens.
    Lohmann-Matthes ML; Koren HS; Fischer H
    Int Arch Allergy Appl Immunol; 1972; 42(1):110-7. PubMed ID: 4623122
    [No Abstract]   [Full Text] [Related]  

  • 9. In vivo activity of in vitro immunized lymphocytes. I. Tumor allograft rejection mediated by in vitro activated mouse thymocytes.
    Rouse BT; Wagner H; Harris AW
    J Immunol; 1972 May; 108(5):1353-61. PubMed ID: 4623947
    [No Abstract]   [Full Text] [Related]  

  • 10. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. I. Preferential reactivity of in vitro generated secondary CTL with syngeneic tumor cells.
    Plata F; Jongeneel V; Cerottini JC; Brunner KT
    Eur J Immunol; 1976 Nov; 6(11):823-9. PubMed ID: 187429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of nonspecific cytotoxicity in graft-versus-host reaction as a function of target cell type.
    Singh JN; Sabbadini E; Sehon AH
    Cell Immunol; 1973 Aug; 8(2):280-9. PubMed ID: 4146905
    [No Abstract]   [Full Text] [Related]  

  • 12. Cells mediating specific in vitro cytotoxicity. II. Probable autonomy of thymus-processed lymphocytes (T cells) for the killing of allogeneic target cells.
    Golstein P; Wigzell H; Blomgren H; Svedmyr EA
    J Exp Med; 1972 Apr; 135(4):890-906. PubMed ID: 5018054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alloimmune cytotoxic T cells: Evidence that they recognize serologically defined antigens and bear clonally restricted receptors.
    Bevan MJ
    J Immunol; 1975 Jan; 114(1 Pt 2):316-9. PubMed ID: 123256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intercellular communication in cell-mediated cytotoxicity. Fluorescein transfer between H-2 d target cells and H-2 b lymphocytes in vitro.
    Sellin D; Wallach DF; Fischer H
    Eur J Immunol; 1971 Dec; 1(6):453-8. PubMed ID: 4112276
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on the mechanism of macrophage-mediated cytotoxicity.
    Ziegler FG; Lohmann-Matthes ML; Fischer H
    Int Arch Allergy Appl Immunol; 1975; 48(2):182-91. PubMed ID: 803933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allograft immunity in the mouse. 1. Quantitation and specificity of cytotoxic effector cells after in vitro sensitization.
    MacDonald HR; Phillips RA; Miller RG
    J Immunol; 1973 Aug; 111(2):565-74. PubMed ID: 4123983
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of tumor cell resistance to syngeneic cell-mediated cytotoxicity during growth of ascitic mastocytoma P815Y.
    Biddison WE; Palmer JC
    Proc Natl Acad Sci U S A; 1977 Jan; 74(1):329-33. PubMed ID: 402006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of T-lymphocyte-mediated tumor-specific lysis by alloantisera directed against the H-2 serological specificities of the tumor.
    Germain RN; Dorf ME; Benacerraf B
    J Exp Med; 1975 Oct; 142(4):1023-8. PubMed ID: 809532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-mediated cytotoxicity against ectromelia virus-infected target cells. I. Specificity and kinetics.
    Gardner I; Bowern NA; Blanden RV
    Eur J Immunol; 1974 Feb; 4(2):63-7. PubMed ID: 4211857
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on the induction and expression of T cell-mediated immunity. IV. Non-overlapping populations of alloimmune cytotoxic lymphocytes with specificity for tumor-associated antigens and transplantation antigens.
    Kedar E; Bonavida B
    J Immunol; 1975 Nov; 115(5):1301-8. PubMed ID: 51889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.